Homepage
Medication Guide
Adverse Reactions of Gemtuzumab (Mylotarg)
Gemtuzumab (Mylotarg) is a CD33-targeted antibody-drug conjugate indicated for the treatment of newly diagnosed or relapsed/refractory CD33-positive acute myeloid leukemia.Adverse Reactions of Gemtuzu...
502
Tuesday, December 9th, 2025, 13:14
What Are the Precautions for Using Gemtuzumab (Mylotarg)?
Gemtuzumab (Mylotarg) is a targeted therapy for CD33-positive acute myeloid leukemia (AML), and its use requires strict adherence to standardized clinical operating procedures and monitoring requireme...
502
Tuesday, December 9th, 2025, 13:11
What Are the Indications for Gemtuzumab (Mylotarg)?
Gemtuzumab (Mylotarg) is an innovative CD33-directed antibody-drug conjugate (ADC) that plays a crucial role in the treatment of acute myeloid leukemia (AML). As a targeted therapy, it combines the sp...
503
Tuesday, December 9th, 2025, 11:58
What Are the Purchasing Channels for Gemtuzumab (Mylotarg)?
Gemtuzumab (Mylotarg) is a CD33-directed antibody-drug conjugate that has demonstrated significant efficacy in the treatment of newly diagnosed and relapsed CD33-positive acute myeloid leukemia.What A...
503
Tuesday, December 9th, 2025, 11:55
Adverse Reactions of Trabectedin (Yondelis)
Trabectedin (Yondelis) is an alkylating antineoplastic agent that exerts its antitumor effect by binding to the minor groove of DNA. It is indicated for the treatment of unresectable or metastatic lip...
503
Tuesday, December 9th, 2025, 11:50
Dosage and Administration, Recommended Doses of Canakinumab (Ilaris)
Canakinumab (Ilaris) is an interleukin-1β blocker indicated for the treatment of various autoinflammatory diseases.Dosage and Administration, Recommended Doses of Canakinumab (Ilaris)General Administr...
503
Tuesday, December 9th, 2025, 11:30
What Are the Indications for Canakinumab (Ilaris)?
Canakinumab (Ilaris) is an important biological agent. As an interleukin-1β (IL-1β) blocker, it has extensive clinical application value.What Are the Indications for Canakinumab (Ilaris)?Cryopyrin-Ass...
503
Tuesday, December 9th, 2025, 11:18
What Are the Purchasing Channels for Canakinumab (Ilaris)?
Canakinumab (Ilaris) is a monoclonal antibody targeting interleukin-1β, mainly indicated for the treatment of various autoimmune diseases such as periodic fever syndromes, adult-onset and juvenile-ons...
502
Tuesday, December 9th, 2025, 09:44
How to Use Tirzepatide
Tirzepatide is a long-acting dual GIP/GLP-1 receptor agonist. It promotes insulin secretion and inhibits glucagon release through a glucose concentration-dependent mechanism, and is mainly used for bl...
502
Tuesday, December 9th, 2025, 09:40
What is Tirzepatide?
Tirzepatide is a novel dual receptor agonist classified as a long-acting GIP/GLP-1 receptor agonist. As a significant breakthrough in the treatment of type 2 diabetes mellitus, its unique dual mechani...
502
Monday, December 8th, 2025, 13:42
10 / 184
1832 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved